Bide Pharmatech Co., Ltd. (SHA:688073)

China flag China · Delayed Price · Currency is CNY
53.28
-1.21 (-2.22%)
At close: Mar 20, 2026
Market Cap4.59B -12.3%
Revenue (ttm)1.32B +20.1%
Net Income152.20M +29.6%
EPS1.75 +32.6%
Shares Out86.15M
PE Ratio30.45
Forward PE22.53
Dividend0.90 (1.65%)
Ex-Dividend DateJun 9, 2025
Volume568,090
Average Volume1,184,399
Open54.97
Previous Close54.49
Day's Range53.10 - 55.49
52-Week Range34.30 - 82.88
Beta0.69
RSI39.76
Earnings DateApr 23, 2026

About Bide Pharmatech

Bide Pharmatech Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. Its products are used in life sciences, organic chemistry, analytical chemistry, and other applications. The company was founded in 2007 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2007
Employees 129
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688073
Full Company Profile

Financial Performance

In 2025, Bide Pharmatech's revenue was 1.32 billion, an increase of 20.13% compared to the previous year's 1.10 billion. Earnings were 152.20 million, an increase of 29.61%.

Financial Statements